Position in VRTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,092,309
+$77,771 QoQ
Shares Held
2,199
-3.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#815
of 1,730 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VestGen Advisors, LLC holds $4,407,229 across 7 Biotechnology names. VRTX ranks #2 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
36,912 | $1,306,315 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
2,199 | $1,092,309 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
13,126 | $1,069,900 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,451 | $731,868 | |
| 5 | ABCL |
AbCellera Biologics Inc.
|
19,652 | $154,268 | |
| 6 | IMRX |
Immuneering Corp
|
10,000 | $49,900 | |
| 7 | GOSS |
Gossamer Bio, Inc.
|
16,177 | $2,669 |
All Filings in VRTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,092,309 | 2,199 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,014,538 | 2,272 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $918,960 | 2,027 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $997,115 | 2,546 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,362,757 | 3,061 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,581,967 | 3,263 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||